Search

everythinglearnresearchcommunity

for

Search:↓

The project created a standardized system for classifying skin lesions in lab rats and mice.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

Mice with a mutated Dsg3 gene showed severe symptoms but not the typical blistering of pemphigus vulgaris.

Punctate follicular porokeratosis is a skin condition with specific features seen in hair follicles.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Transplant patients often get skin problems, with treatments varying by condition.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

A new gene variant in the DSP gene is linked to a unique type of hair loss.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Testing hair roots with a special dye is a simple, non-invasive way to check disease progress in pemphigus vulgaris patients.

Skin cancer in sun-exposed areas is more likely to come back.

Dermoscopy is an effective tool for accurately detecting skin cancers.

Darier-White disease causes skin and nail issues, starts around age 20, worsens until 40-50, and has poor treatment options.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.